Ana Paula Cunha Chaves

Ana Paula Cunha Chaves

Auto-generated profile, based on publicly available information

Ana Paula Cunha Chaves

Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
VPVictor C. Passarelli
Victor C. Passarelli
KFKlinger Faico-Filho
Klinger Faico-Filho
LMLuiz Vinicius Leão Moreira
Luiz Vinicius Leão Moreira
ACAna Paula Cunha
Ana Paula Cunha
JCJoseane Mayara Almeida Carvalho
Joseane Mayara Almeida Carvalho
NBNancy Bellei
Nancy Bellei
• In one day, 4% (six of 150) of hospital visitors had asymptomatic COVID-19. • Potential of visitors’ viral shedding in healthcare facilities is underestimated. • SARS-CoV-2 introduction into facilities is not fully blocked by universal masking.

28 April 2022 in Brazilian Journal of Microbiology
Verified
Journal Article
Closed access
PDF file
JCJoseane Mayara Almeida Carvalho
Joseane Mayara Almeida Carvalho
CCClarice Neves Camargo
Clarice Neves Camargo
Luciano Kleber de Souza LunaLuciano Kleber de Souza Luna
Luciano Kleber de Souza Luna
ARAnna Clara Rabha
Anna Clara Rabha
DCDANIELLE DIAS CONTE
DANIELLE DIAS CONTE
NBNancy Bellei
Nancy Bellei

1 February 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
GBGabriela Barbosa
Gabriela Barbosa
ACAna Paula Cunha Chaves
Ana Paula Cunha Chaves
Luciano Kleber de Souza LunaLuciano Kleber de Souza Luna
Luciano Kleber de Souza Luna
NBNancy Bellei
Nancy Bellei
Click on the article title to read more.

1 January 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MTMonica Taminato
Monica Taminato
ACAna Paula Cunha Chaves
Ana Paula Cunha Chaves
RMRicharlisson Borges de Morais
Richarlisson Borges de Morais
LMLuiz Vinicius Leão Moreira
Luiz Vinicius Leão Moreira
DCDANIELLE DIAS CONTE
DANIELLE DIAS CONTE
NBNancy Bellei
Nancy Bellei
Background Health Care workers (HCW) are an important group affected by this pandemic and COVID-19 has presented substantial challenges for health professionals and health systems in many countries. The Brazilian vaccination plan implemented in October, so that third dose for HCW. However, the persistence of CoronaVac vaccine-induced immunity is unknown, and immunogenicity according to age cohorts may differ among individuals. Objective Evaluate the post vaccination immune humoral response and the relationship between post-vaccination seropositivity rates and demographic data among Healthcare Workers over 6 months after CoronaVac immunization. Methods A cross section study including Healthcare professionals vaccinated with CoronaVac for 6 months or more. The study was carried with the analysis of post-vaccination serological test to assess the levels of humoral response after vaccination. Results 329 participants were included. Among them, 76% were female. Overall, 18.5% were positive quantitative titles (IQR 42.87-125.5) and the negative group was 80%, quantitative titles (IQR 5.50-13.92). Conclusion It was possible to identify a group with positive quantitative titles in serological test for IgG antibody against the SARS-CoV-2. Further investigation is required to determine the durability of post-vaccination antibodies and how serological tests can be determine the ideal timing of vaccine booster doses.

1 January 2021 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
ACAna Paula Cunha Chaves
Ana Paula Cunha Chaves
GBGabriela Barbosa
Gabriela Barbosa
LMLuiz Vinicius Leão Moreira
Luiz Vinicius Leão Moreira
JCJoseane Mayara de Almeida Carvalho
Joseane Mayara de Almeida Carvalho
APAna Helena Sitta Perosa
Ana Helena Sitta Perosa
NBNancy Bellei
Nancy Bellei